SymBio Pharmaceuticals Ltd SBIZF:Grey Market

RT Quote | Exchange | USD
Last | 03/01/21 EST
2.90UNCH (UNCH)
52 week range
2.90 - 2.90

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.90
  • 52 Week High2.90
  • 52 Week High Date03/01/21
  • 52 Week Low2.90
  • 52 Week Low Date03/01/21
  • Market Cap482.62M
  • Shares Out38.17M
  • 10 Day Average Volume3,884
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-2.40
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest SymBio Pharmaceuticals Ltd News

There is no recent news for this security.

Latest SBIZF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The Company develops new medicines using chemical compounds proofed by preclinical tests and clinical...
Fuminori Yoshida
Chief Executive Officer
Takaaki Fukushima
Chief Financial Officer
Address
Toranomon 30 Mori Bldg.
3-2-2, Toranomon
Minato-ku, TKY
105-0001
Japan